Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients

Background. Features of nonalcoholic fatty liver disease (NAFLD) have yet to be described in the Canadian First Nations (FN) population. The aim of this study was to compare the prevalence, severity, and outcome of NAFLD in FN versus non-FN patients at an urban, tertiary care centre. Methods. Adults...

Full description

Bibliographic Details
Published in:Canadian Journal of Gastroenterology and Hepatology
Main Authors: Julia Uhanova, Gerald Minuk, Federico Lopez Ficher, Natasha Chandok
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2016
Subjects:
Online Access:https://doi.org/10.1155/2016/6420408
https://doaj.org/article/bbb1457b886a4fa29510b5b9e8340a3f
id ftdoajarticles:oai:doaj.org/article:bbb1457b886a4fa29510b5b9e8340a3f
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:bbb1457b886a4fa29510b5b9e8340a3f 2024-09-15T18:06:30+00:00 Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients Julia Uhanova Gerald Minuk Federico Lopez Ficher Natasha Chandok 2016-01-01T00:00:00Z https://doi.org/10.1155/2016/6420408 https://doaj.org/article/bbb1457b886a4fa29510b5b9e8340a3f EN eng Wiley http://dx.doi.org/10.1155/2016/6420408 https://doaj.org/toc/2291-2789 https://doaj.org/toc/2291-2797 2291-2789 2291-2797 doi:10.1155/2016/6420408 https://doaj.org/article/bbb1457b886a4fa29510b5b9e8340a3f Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016) Diseases of the digestive system. Gastroenterology RC799-869 article 2016 ftdoajarticles https://doi.org/10.1155/2016/6420408 2024-08-05T17:48:37Z Background. Features of nonalcoholic fatty liver disease (NAFLD) have yet to be described in the Canadian First Nations (FN) population. The aim of this study was to compare the prevalence, severity, and outcome of NAFLD in FN versus non-FN patients at an urban, tertiary care centre. Methods. Adults with NAFLD and no additional liver disease were identified in a prospectively derived database at the University of Manitoba. Demographic, clinical, laboratory, imaging, and histologic data were analyzed. Results. 482 subjects fulfilled diagnostic criteria for NAFLD, including 33 (7%) FN. Aside from rural residence, diabetes and cholestasis being more common in FN patients, the ages, gender distributions, clinical and radiologic features, and liver enzyme/function test results were similar in the two cohorts. Noninvasive tests of fibrosis (APRI and NAFLD fibrosis scores) were also similar in the two cohorts. There were no significant differences in liver enzyme or function tests in either cohort after approximately three years of follow-up. Conclusion. Compared to the prevalence of FN persons in the general population of this study site (10–15%), FN patients were underrepresented in this NAFLD population. The severity and progression of liver disease in FN patients appear to be similar to those in non-FN patients. Article in Journal/Newspaper First Nations Directory of Open Access Journals: DOAJ Articles Canadian Journal of Gastroenterology and Hepatology 2016 1 6
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle Diseases of the digestive system. Gastroenterology
RC799-869
Julia Uhanova
Gerald Minuk
Federico Lopez Ficher
Natasha Chandok
Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
topic_facet Diseases of the digestive system. Gastroenterology
RC799-869
description Background. Features of nonalcoholic fatty liver disease (NAFLD) have yet to be described in the Canadian First Nations (FN) population. The aim of this study was to compare the prevalence, severity, and outcome of NAFLD in FN versus non-FN patients at an urban, tertiary care centre. Methods. Adults with NAFLD and no additional liver disease were identified in a prospectively derived database at the University of Manitoba. Demographic, clinical, laboratory, imaging, and histologic data were analyzed. Results. 482 subjects fulfilled diagnostic criteria for NAFLD, including 33 (7%) FN. Aside from rural residence, diabetes and cholestasis being more common in FN patients, the ages, gender distributions, clinical and radiologic features, and liver enzyme/function test results were similar in the two cohorts. Noninvasive tests of fibrosis (APRI and NAFLD fibrosis scores) were also similar in the two cohorts. There were no significant differences in liver enzyme or function tests in either cohort after approximately three years of follow-up. Conclusion. Compared to the prevalence of FN persons in the general population of this study site (10–15%), FN patients were underrepresented in this NAFLD population. The severity and progression of liver disease in FN patients appear to be similar to those in non-FN patients.
format Article in Journal/Newspaper
author Julia Uhanova
Gerald Minuk
Federico Lopez Ficher
Natasha Chandok
author_facet Julia Uhanova
Gerald Minuk
Federico Lopez Ficher
Natasha Chandok
author_sort Julia Uhanova
title Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_short Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_full Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_fullStr Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_full_unstemmed Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_sort nonalcoholic fatty liver disease in canadian first nations and non-first nations patients
publisher Wiley
publishDate 2016
url https://doi.org/10.1155/2016/6420408
https://doaj.org/article/bbb1457b886a4fa29510b5b9e8340a3f
genre First Nations
genre_facet First Nations
op_source Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
op_relation http://dx.doi.org/10.1155/2016/6420408
https://doaj.org/toc/2291-2789
https://doaj.org/toc/2291-2797
2291-2789
2291-2797
doi:10.1155/2016/6420408
https://doaj.org/article/bbb1457b886a4fa29510b5b9e8340a3f
op_doi https://doi.org/10.1155/2016/6420408
container_title Canadian Journal of Gastroenterology and Hepatology
container_volume 2016
container_start_page 1
op_container_end_page 6
_version_ 1810443920043147264